Vincerx Pharma, Inc.
VINCDelisted Apr 28, 2025- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001796129
Vincerx Pharma, Inc. was delisted on Apr 28, 2025; its insiders filed their last Form 4 on Aug 14, 2024; 14 institutions reported holding it in 13F filings for Q1 2025, worth $116.8K in total; no superinvestor held it.
Q2 2024 vs. Q1 2024
How the institutions holding Vincerx Pharma, Inc. changed between Q1 2024 and Q2 2024.
All holders in Q2 2024All holders in Q1 2024
| Measure | Q1 2024 | Q2 2024 | Change |
|---|---|---|---|
| Holders | 38 | 28 | −10 |
| Shares | 8.46M | 10.7M | +2.24M (+26.4%) |
| Value | $42.7M | $8.66M | −$34.1M (−79.7%) |
New holders (5)
Institutions that held Vincerx Pharma, Inc. at the end of Q2 2024 but not at the end of Q1 2024.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Prosight Management, LP | 2,488,418 | $2.02M | 0.60% |
| Armistice Capital, LLC | 1,988,000 | $1.61M | 0.04% |
| XTX Topco Ltd | 18,181 | $14.7K | 0.00% |
| Two Sigma Investments, LP | 17,023 | $13.8K | 0.00% |
| Bank & Trust Co | 1,000 | $810 | 0.00% |
Sold out (15)
Institutions that held Vincerx Pharma, Inc. at the end of Q1 2024 and filed for Q2 2024 without it.
| Institution | Shares, Q1 2024 | Value, Q1 2024 |
|---|---|---|
| Octagon Capital Advisors LP | 1,000,000 | $5.06M |
| Kingdon Capital Management, L.L.C. | 385,000 | $1.95M |
| Sio Capital Management, LLC | 102,049 | $516.4K |
| Eversept Partners, LP | 79,588 | $402.7K |
| Price T Rowe Associates Inc | 30,000 | $152.0K |
| Jane Street Group, LLC | 29,318 | $148.3K |
| Woodline Partners LP | 23,645 | $119.6K |
| Vontobel Holding Ltd. | 15,000 | $75.9K |
| American Century Companies Inc | 11,789 | $59.7K |
| Cresset Asset Management, LLC | 10,000 | $50.6K |
| Acadian Asset Management LLC | 5,259 | $26.0K |
| ICA Group Wealth Management, LLC | 300 | $1.52K |
| Wells Fargo & Company | 160 | $810 |
| Barclays PLC | 23 | $116 |
| Macquarie Group Ltd | 266 | $1 |